Sloan-Kettering Cancer Center Memorial, 10% Owner at Actinium Pharmaceuticals, Inc. (ATNM), sold 20,840 shares at $1.82 ($38K) on 2016-07-05, disclosed to the SEC on 2016-07-07.
Open-market sale of $38k ATNM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.82 | 6,000 | $11K | 28.9% |
| 2 | $1.83 | 4,340 | $8K | 21.0% |
| 3 | $1.80 | 10,500 | $19K | 50.1% |
| Total | $1.81 avg | 20,840 | $38K | 100% |
| Filing → |
| ATNM | SELL | 2016-08-17 | $17K | — | Filing → |
| ATNM | SELL | 2016-07-14 | $6K | — | Filing → |
| ATNM | SELL | 2016-07-12 | $40K | — | Filing → |